Ahmed Kamal

6PUBLICATIONS
21CO-AUTHORS
Major global burdens of diseaseCellular immunologyTe mātai huingaira o te Māori (Māori genomics)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 22, 2026
LIMITED DIAGNOSTIC ACCURACY OF FIB-4 FOR DETECTING SIGNIFICANT LIVER FIBROSIS IN CHRONIC HEPATITIS B: A CROSS-SECTIONAL STUDY.

|Jul 24, 2024
MYELOID-DERIVED SUPPRESSOR CELLS TWO YEARS AFTER HEPATITIS C VIRUS ERADICATION USING DIRECTLY ACTING ANTIVIRALS.

Dania Abunawas, Amany Abbasy, Mohamed Afifi

|Apr 27, 2024
Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population.

Nehal Elmansoury, Ahmed A Megahed, Ahmed Kamal

|Mar 04, 2024
Hepatitis C Virus-Related One-Year Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial.

Ahmed Kamal, Marwa Metawea, Heba Omar

|Jan 20, 2023
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.

Ahmed Kamal, Ramy Mohamed Ghazy, Dalia Sherief

|Jul 13, 2022
ASSESSING PREDICTORS OF DIRECTLY ACTING ANTIVIRALS' FAILURE AS A FURTHER STEP TOWARDS MORE EFFICIENT HCV ELIMINATION PROGRAMS: IL28B (IFNL4) GENE POLYMORPHISM HAS NO ROLE WHILE HIGHER ESTIMATED CREATININE CLEARANCE IS A FORGOTTEN FACTOR.

Ahmed Kamal, Cecil Matta, Heba Akram Mohsin

Pageof 1

Frequent Collaborators

2 joint publications

Ramy Mohamed Ghazy

2 joint publications

Heba Hany Omar

1 joint publications

Cecil Matta

1 joint publications

Heba Akram Mohsin